Therapeutic Potential of MicroRNA: A New Target to Treat Intrahepatic Portal Hypertension?

Figure 2

Summary of the miRNAs and the TGF-β pathway involved in HSCs. The particular TGF-β signaling pathway affected by miRNAs is described in detail in the review.